SlideShare a Scribd company logo
Dr sandeep
GMC
About G6PD Enzyme
 It is the first enzyme of HMP Pathway which is the
only source of NADPH in RBC.
 Critical for protecting red cells against oxidant injury.
 Active form of G6PD enzyme is a dimer.
 Monomer – 515 amino acids
 Molecular weight – 59 kd.
HMP shunt
Glucose-6-phosphate Dehydrogenase Deficiency
is the most common enzyme deficiency affecting
about 400 million people worldwide.
Characterised by reduced activity of G6PD in RBCs
and occurrence of hemolysis usually after exposure to
oxidative stress.
 G6PD located on X chromosome.
 X linked recessive inheritence.
Etiology
G6PD deficiency , X-linked hereditary disorder caused by
mutations in the G6PD gene at q28 locus.
The q28 locus of the X-
chromosome…
Phenotype
• As an X-linked disorder, G6PD deficiency mainly affect males.
• Females are heterozygous, and mostly asymptomatic.
• Expression of G6PD deficiency in females is variable, due to
random inactivation of one X chromosome (lyonization) during
embryogenesis and depends on relative proportion of normal and
abnormal chromosome that are inactivated.
• Homozygous females showing clinical features have also been
reported.
Classification of genetic Variants of
G6PD
 The World Health Organization classifies G6PD genetic
variants into five classes on the basis of magnitude of enzyme
deficiency and also on severity of hemolysis.
The first three of which are deficiency states.
 Class I- Very Severe deficiency (<10% activity) with chronic
(nonspherocytic) hemolytic anemia
 Class II -Severe deficiency (<10% activity), with intermittent
hemolysis
 Class III – Mild to Moderate deficiency (10-60% activity),
hemolysis with stressors only
 Class IV - Non-deficient variant, no clinical sequelae
 Class V - Increased enzyme activity, no clinical sequelae
Oxidative stress
Bulidup of cellular oxidants
Cross linking of – SH group of globin chain
l/t denaturation
Formation of membrane bound
precipitates (Heinz bodies)
Severely damage the
membrane l/t IVH
Less severe membrane damage l/t reduced deformability
Heinz body containg RBCs passes through splenic cords
,macrophages pluck these bodies.
Bite cells,
Phagocytosed by splenic macrophages EVH
G6PD Variants
Variants Activity Hemolysis WHO
class
Race
G6PD B Normal No Class IV Caucasians ,
Asians &
Blacks
G6PD A+ Normal No Class IV African
Blacks
G6PD A- Reduced Mild to Mod. Class III Blacks
G6PD
Mediterranean
Markedly
Reduced
Severe Class II Caucasians
G6PD Canton Markedly
Reduced
Severe Asians
G6PD variants
 There are over 400 variants of the G6PD enzyme.
 G6PD A-: Most common type
 Half life of enzyme – 13 days
 Older RBCs are deficient in enzyme so on exposure to
oxidative stress older RBCs are rapidly destroying.
Whereas younger RBCs having enzymatic activity thus
hemolytic episode is self limiting.
 Confers protection against Malaria.
 G6PD B: Enzyme normal
 Half life of enzyme- 62 days
 No hemolysis takes place.
G6PD variants
 G6PD Mediterranean :
 Half life – 1 day
 Severe hemolysis
 Enzyme is deficient in both young & old red blood cells.
 More severe than G6PD A.
Common Variants in India
 G6PD Mediterranean
 G6PD Kerala-kalyan
 G6PD orissa
 G6PD deficiency commonly seen in Parsees and Vataliya
Prajapatis
• G6PD is the first enzyme in the hexose
monophosphate shunt, a pathway critical for
generating nicotinamide adenine dinucleotide
phosphate (NADPH).
• NADPH is required for the regeneration of reduced
glutathione.
• Reduced glutathione is used for the detoxification of
oxidants produced by the interaction of hemoglobin
and oxygen and by exogenous factors such as
drugs, infection, and metabolic acidosis.
Pathophysiology
Pathogenesis
 Normally when RBCs are exposed to drugs & toxins
which generated free radicals , glucose metabolism via
HMP shunt increased.
 Larger amount of reduced glutathione is generated
which inactivate oxygen radicals.
Pathogenesis
Oxidative stress
Bulidup of cellular oxidants
Cross linking of – SH group of globin chain
l/t denaturation
Formation of membrane bound
precipitates (Heinz bodies)
Severely damage the
membrane l/t IVH
Less severe membrane damage l/t reduced deformability
Heinz body containg RBCs passes through splenic cords
,macrophages pluck these bodies.
Bite cells,
Phagocytosed by splenic macrophages EVH
Oxidative triggers
 Infections:
 Viral hepatitis
 Typhoid fever
 Pneumonia
 Drugs
 Antimalarial – Primaquine, Chloroquine
 Sulfonamides – dapsone, Septran
 Nitrofurantoin
 Analgesics – Acetyl salicylic acid
 Certain food
 Fava beans
Clinical Presentation
 Acute hemolytic anemia
 Drug induced
 Infection induced
 Neonatal hyperbilirubinemia
 Hemolysis associated with diabetic acidosis
 Favism
 Chronic nonspherocytic hemolytic anemia
Acute hemolytic anemia
 Acute hemolysis usually occur after-
 infection,
 exposure to an oxidative drug.
 Self limited- class III variant
 affecting older erythrocytes first, younger erythrocytes and reticulocytes
that typically have higher levels of enzyme activity are able to sustain the
oxidative damage without hemolysis.
 In class II variant, hemolysis is marked affecting all stages of RBC hence
not self limited.
 Hemolysis typically occurs- 24 to 72 hours after ingestion.
 There is sudden development pallor,
 dark coloured urine,
 back or abdominal pain
 Yellowish discolouration of skin and sclera.
Favism
 The disorder favism results from hemolysis secondary to the
ingestion of fava bean.
 Commonly associated with G6PD Mediterranean.
 Most commonly seen in Italy, Greece and middle east.
 Fava beans contain naturally occurring oxidants
 Pyrimidine aglycone, devicine and isouramil.
 Affects children 1-5 yrs of age.
 Peak seasonal incidence April and May.
 Characterized by acute intravascular hemolysis
 Headache, nausea, back pain , fever with chills and rigors.
 Followed by hemoglobinuria anemia and jaundice.
Chronic nonspherocytic hemolytic
anemia.
 Patients with chronic nonspherocytic hemolytic anemia
generally have a profound deficiency of G6PD that causes
chronic anemia and an increased susceptibility to
infection.
 The susceptibility to infection arises because the NADPH
supply within granulocytes is inadequate to sustain the
oxidative burst necessary for killing of phagocytosed
bacteria.
Investigations
 Complete blood count and reticulocyte count;
 Peripheral smear for Heinz bodies
 Liver enzymes (to exclude other causes of jaundice);
 LDH (Lactate dehydrogenase) (elevated in hemolysis
and a marker of hemolytic severity)
 Haptoglobin (decreased in hemolysis);
 A "direct antiglobulin test" (Coombs' test) – this
should be negative, as hemolysis in G6PD is not
immune-mediated;
Lab findings
 Fall in Hb to 6-10g/dl
 Increased Reticulocyte count by 20-30 %
 Inreased unconjugated bilirubin
 Increased Urobilinogen
 Increased LDH
 Decreased Haptoglobin
 Hemoglobinemia
 Hemoglobinuria
 Peripheral Smear shows-
 Heinz Bodies
 Fragmented red cells
 Anisopoikilocytosis with polychromatic RBCs
 Bite cells
HEINZ BODIES : BITE CELLS
Screening Test
 Beutler fluorescent spot test
 Methhemoglobin reduction test
 Dye decolorisation test
Fluoroscent Spot Test
 Detecting the generation of NADPH from NADP. As NADPH
fluoresce under UV light while NADP fails to do so. The test is
positive if the blood spot fails to fluoresce under ultraviolet light.
 Procedure
 Reagent mixture + Whole Blood
A Drop of This Mixture
Applied to filter paper
Examined under UV light
Glucose 6 phosphate
NADP
Saponin & Oxidised
glutathione
Methhemoglobin Reduction Test
 Sodium nitrite oxidises oxyhemoglobin to
methhemoglobin
 Methylene blue is a redox dye that reduces
methhemoglobin to hemoglobin in G6PD normal red cell
but not in deficient RBC.
 Methhemoglobin imparts brownish color which indicate
G6PD deficiency.
MethHb
Oxyhemoglobin
Dye Decolourization Test
 Hemolysate incubated with buffered solution of
dichlorophenol Indophenol, glucose 6 phosphate, and
NADP.
 If G6PD exist in Hemolysate NADPH is generated which
reduces the dye to colorless compound.
 In G6PD deficiency time taken for dye decolourization is
longer.
Diagnosis
 Quantitative G6PD assay
 In patients with acute hemolysis, testing for G6PD deficiency
may be falsely negative because older erythrocytes with a
higher enzyme deficiency have been hemolyzed. Young
erythrocytes and reticulocytes have normal or near-normal
enzyme activity.
 So enzyme assay should be performed 2-3 months after acute
hemolysis.
 Quantitative spectrophotometric analysis
 Tests based on Polymerase chain reaction
 detect specific mutations and are used for population
screening, family studies, or prenatal diagnosis.
G6PD deficiency should be suspected in patients of
African, Mediterranean, or Asian ancestry who present
with either an acute hemolytic episode or neonatal
jaundice.
The key to management of G6PD deficiency is
prevention of hemolysis by prompt:
1- treatment of infections
2- avoidance of oxidant drugs (e.g., sulfonamides,
sulfones, nitrofurans) and toxins (e.g., naphthalene).
Although most patients with a hemolytic episode
will not require medical intervention, those with severe
anemia and hemolysis may require resuscitation and
Treatment
Correlation with Malaria
• In areas in which malaria is endemic, G6PD deficiency has a
prevalence of 5% to 25%; in nonendemic areas, it has a prevalence
of less than 0.5% .
• G6PD deficient RBC does not allow parasite to grow since the ribose
metabolite required for nucleic acid synthesis in malaria parasite are
not available.
• This protection is largely limited to heterozygous females.

More Related Content

What's hot

G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
HariharanK48
 
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaDebra G. Carnahan
 
G6pd
G6pdG6pd
G6PD deficiency.ppt
G6PD deficiency.pptG6PD deficiency.ppt
G6PD deficiency.ppt
AbdulKaderSouid
 
Hemolytic Anemia Investigation - By Mohan kumar
Hemolytic Anemia Investigation - By Mohan kumarHemolytic Anemia Investigation - By Mohan kumar
Hemolytic Anemia Investigation - By Mohan kumar
Schin Dler
 
Hemolytic anemia sandip
Hemolytic anemia sandipHemolytic anemia sandip
Hemolytic anemia sandip
Sandip Gupta
 
Interpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin studyInterpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin study
Dr. Rajesh Bendre
 
practical points for G6PD Deficiency , Favism
practical points for G6PD Deficiency , Favismpractical points for G6PD Deficiency , Favism
practical points for G6PD Deficiency , Favism
Hussein Abdeldayem
 
Paroxysmal nocturnal hematuria
Paroxysmal nocturnal hematuriaParoxysmal nocturnal hematuria
Paroxysmal nocturnal hematuria
Aseem Jain
 
Porphyrias and lab diagnosis
Porphyrias and lab diagnosisPorphyrias and lab diagnosis
Porphyrias and lab diagnosis
gargitignath12
 
Platelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx finalPlatelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx final
Anupam Singh
 
Estimation of iron profile
Estimation of  iron profileEstimation of  iron profile
Estimation of iron profile
Sk. Mizanur Rahman
 
G6 Pd Deficiency
G6 Pd DeficiencyG6 Pd Deficiency
G6 Pd Deficiency
bnavabi
 
Hemoglobinopathies
HemoglobinopathiesHemoglobinopathies
Hemoglobinopathies
Ali Faris
 
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
Chetan Ganteppanavar
 
Megaloblastic anemia mak
Megaloblastic anemia makMegaloblastic anemia mak
Megaloblastic anemia mak
Bahoran Singh Rajput
 
Hemoglobinopathies - Lab diagnosis
Hemoglobinopathies - Lab diagnosisHemoglobinopathies - Lab diagnosis
Hemoglobinopathies - Lab diagnosis
Ankit Raiyani
 

What's hot (20)

G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
 
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
 
G6pd
G6pdG6pd
G6pd
 
G6PD deficiency.ppt
G6PD deficiency.pptG6PD deficiency.ppt
G6PD deficiency.ppt
 
Hemolytic Anemia Investigation - By Mohan kumar
Hemolytic Anemia Investigation - By Mohan kumarHemolytic Anemia Investigation - By Mohan kumar
Hemolytic Anemia Investigation - By Mohan kumar
 
Hemolytic anemia sandip
Hemolytic anemia sandipHemolytic anemia sandip
Hemolytic anemia sandip
 
Interpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin studyInterpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin study
 
practical points for G6PD Deficiency , Favism
practical points for G6PD Deficiency , Favismpractical points for G6PD Deficiency , Favism
practical points for G6PD Deficiency , Favism
 
Paroxysmal nocturnal hematuria
Paroxysmal nocturnal hematuriaParoxysmal nocturnal hematuria
Paroxysmal nocturnal hematuria
 
G6pd
G6pdG6pd
G6pd
 
Haemolytic anemia
Haemolytic anemia Haemolytic anemia
Haemolytic anemia
 
Porphyrias and lab diagnosis
Porphyrias and lab diagnosisPorphyrias and lab diagnosis
Porphyrias and lab diagnosis
 
Platelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx finalPlatelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx final
 
Estimation of iron profile
Estimation of  iron profileEstimation of  iron profile
Estimation of iron profile
 
G6 Pd Deficiency
G6 Pd DeficiencyG6 Pd Deficiency
G6 Pd Deficiency
 
Hemoglobinopathies
HemoglobinopathiesHemoglobinopathies
Hemoglobinopathies
 
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
Sideroblastic anemia - Etiopathogenesis, Clinical features, Advances in Manag...
 
Megaloblastic anemia mak
Megaloblastic anemia makMegaloblastic anemia mak
Megaloblastic anemia mak
 
Le cell
Le cellLe cell
Le cell
 
Hemoglobinopathies - Lab diagnosis
Hemoglobinopathies - Lab diagnosisHemoglobinopathies - Lab diagnosis
Hemoglobinopathies - Lab diagnosis
 

Similar to G6PD disease.pptx

Blood 111.pptx
Blood 111.pptxBlood 111.pptx
Blood 111.pptx
PariaMotahari1
 
Acute hemolytic anemia
Acute hemolytic anemiaAcute hemolytic anemia
Acute hemolytic anemia
MohamedEid822594
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
Fatima Avci
 
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyHemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyThe Medical Post
 
NEONATAL G-6PD DEFICIENCY
NEONATAL G-6PD DEFICIENCYNEONATAL G-6PD DEFICIENCY
Medicine 5th year, 8th lecture/part one (Dr. Sabir)
Medicine 5th year, 8th lecture/part one (Dr. Sabir)Medicine 5th year, 8th lecture/part one (Dr. Sabir)
Medicine 5th year, 8th lecture/part one (Dr. Sabir)
College of Medicine, Sulaymaniyah
 
Glucose 6-phosphate dehydrogenase deficiency anemia.pptx
Glucose 6-phosphate dehydrogenase deficiency anemia.pptxGlucose 6-phosphate dehydrogenase deficiency anemia.pptx
Glucose 6-phosphate dehydrogenase deficiency anemia.pptx
saifurrahmanSapai
 
hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)Afrina Qureshi
 
ANEMIA HEMOLITICA-INDIA.ppt
ANEMIA HEMOLITICA-INDIA.pptANEMIA HEMOLITICA-INDIA.ppt
ANEMIA HEMOLITICA-INDIA.ppt
Ruben Silva Ames
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
DR. JITHIN GEORGE
 
Hereditary Hemolytic Anemias
Hereditary Hemolytic AnemiasHereditary Hemolytic Anemias
Hereditary Hemolytic Anemias
jaiminmanek4
 
Khan arbaz ali
Khan arbaz aliKhan arbaz ali
Khan arbaz ali
khan ali
 
Hemolytic anemia 3
Hemolytic anemia 3Hemolytic anemia 3
Hemolytic anemia 3
05813
 
Hemolytic Anemia
Hemolytic Anemia Hemolytic Anemia
Hemolytic Anemia
Theekshana Wijesinghe
 
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptxglucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
KalyanAcharya10
 
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
TunTunWin34
 

Similar to G6PD disease.pptx (20)

Blood 111.pptx
Blood 111.pptxBlood 111.pptx
Blood 111.pptx
 
Acute hemolytic anemia
Acute hemolytic anemiaAcute hemolytic anemia
Acute hemolytic anemia
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyHemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
 
NEONATAL G-6PD DEFICIENCY
NEONATAL G-6PD DEFICIENCYNEONATAL G-6PD DEFICIENCY
NEONATAL G-6PD DEFICIENCY
 
Medicine 5th year, 8th lecture/part one (Dr. Sabir)
Medicine 5th year, 8th lecture/part one (Dr. Sabir)Medicine 5th year, 8th lecture/part one (Dr. Sabir)
Medicine 5th year, 8th lecture/part one (Dr. Sabir)
 
Glucose 6-phosphate dehydrogenase deficiency anemia.pptx
Glucose 6-phosphate dehydrogenase deficiency anemia.pptxGlucose 6-phosphate dehydrogenase deficiency anemia.pptx
Glucose 6-phosphate dehydrogenase deficiency anemia.pptx
 
BCP G6PD-2
BCP G6PD-2BCP G6PD-2
BCP G6PD-2
 
hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)hemolytic anemia (cell membrane defect)
hemolytic anemia (cell membrane defect)
 
ANEMIA HEMOLITICA-INDIA.ppt
ANEMIA HEMOLITICA-INDIA.pptANEMIA HEMOLITICA-INDIA.ppt
ANEMIA HEMOLITICA-INDIA.ppt
 
Haematology notes
Haematology notesHaematology notes
Haematology notes
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Hereditary Hemolytic Anemias
Hereditary Hemolytic AnemiasHereditary Hemolytic Anemias
Hereditary Hemolytic Anemias
 
Khan arbaz ali
Khan arbaz aliKhan arbaz ali
Khan arbaz ali
 
Hemolytic anemia 3
Hemolytic anemia 3Hemolytic anemia 3
Hemolytic anemia 3
 
Hemolytic Anemia
Hemolytic Anemia Hemolytic Anemia
Hemolytic Anemia
 
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptxglucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
glucose-6-phosphatedehydrogenasedeficiency2-190629154837.pptx
 
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
2.P.vivax and G6PD_PAVE_25112022_PSI.pptx
 
Rbc Patho B
Rbc  Patho BRbc  Patho B
Rbc Patho B
 
Rbc Patho B
Rbc  Patho BRbc  Patho B
Rbc Patho B
 

More from sandeep singh

White Blood Cells.pptx
White Blood Cells.pptxWhite Blood Cells.pptx
White Blood Cells.pptx
sandeep singh
 
PS Findings In Hemolytic Anemia.pptx
PS Findings In Hemolytic Anemia.pptxPS Findings In Hemolytic Anemia.pptx
PS Findings In Hemolytic Anemia.pptx
sandeep singh
 
Transfusion Transmitted Reaction.pptx
Transfusion Transmitted Reaction.pptxTransfusion Transmitted Reaction.pptx
Transfusion Transmitted Reaction.pptx
sandeep singh
 
female reproductive system.pptx
female reproductive system.pptxfemale reproductive system.pptx
female reproductive system.pptx
sandeep singh
 
male Reproductive system.pptx
male Reproductive system.pptxmale Reproductive system.pptx
male Reproductive system.pptx
sandeep singh
 
Cartilage&_Bone.pptx
Cartilage&_Bone.pptxCartilage&_Bone.pptx
Cartilage&_Bone.pptx
sandeep singh
 
histology of epithelial and connective tissue.pptx
histology of epithelial and connective tissue.pptxhistology of epithelial and connective tissue.pptx
histology of epithelial and connective tissue.pptx
sandeep singh
 
Digestive System Liver, Gall Bladder and Pancreas.pptx
Digestive System Liver, Gall Bladder and Pancreas.pptxDigestive System Liver, Gall Bladder and Pancreas.pptx
Digestive System Liver, Gall Bladder and Pancreas.pptx
sandeep singh
 
LE cell.ppt
LE cell.pptLE cell.ppt
LE cell.ppt
sandeep singh
 
Cytology stain.pptx
Cytology stain.pptxCytology stain.pptx
Cytology stain.pptx
sandeep singh
 
Urinary System Histology.pptx
Urinary System Histology.pptxUrinary System Histology.pptx
Urinary System Histology.pptx
sandeep singh
 
Alimentary system.pptx
Alimentary system.pptxAlimentary system.pptx
Alimentary system.pptx
sandeep singh
 
MICROSCOPE (1).pptx
MICROSCOPE (1).pptxMICROSCOPE (1).pptx
MICROSCOPE (1).pptx
sandeep singh
 
Nervous tissue.pptx
Nervous tissue.pptxNervous tissue.pptx
Nervous tissue.pptx
sandeep singh
 
ENDOCRINE SYSTEM 2.pptx
ENDOCRINE SYSTEM 2.pptxENDOCRINE SYSTEM 2.pptx
ENDOCRINE SYSTEM 2.pptx
sandeep singh
 
Investigation in mismatch blood transfusion.pptx
Investigation in mismatch blood transfusion.pptxInvestigation in mismatch blood transfusion.pptx
Investigation in mismatch blood transfusion.pptx
sandeep singh
 
Normal hemostasis.pptx
Normal hemostasis.pptxNormal hemostasis.pptx
Normal hemostasis.pptx
sandeep singh
 
Gland.pptx
Gland.pptxGland.pptx
Gland.pptx
sandeep singh
 
differentialleucocytecount.pptx
differentialleucocytecount.pptxdifferentialleucocytecount.pptx
differentialleucocytecount.pptx
sandeep singh
 
hemoglobinestimation2022-220717075634-6da2d22b (1).pptx
hemoglobinestimation2022-220717075634-6da2d22b (1).pptxhemoglobinestimation2022-220717075634-6da2d22b (1).pptx
hemoglobinestimation2022-220717075634-6da2d22b (1).pptx
sandeep singh
 

More from sandeep singh (20)

White Blood Cells.pptx
White Blood Cells.pptxWhite Blood Cells.pptx
White Blood Cells.pptx
 
PS Findings In Hemolytic Anemia.pptx
PS Findings In Hemolytic Anemia.pptxPS Findings In Hemolytic Anemia.pptx
PS Findings In Hemolytic Anemia.pptx
 
Transfusion Transmitted Reaction.pptx
Transfusion Transmitted Reaction.pptxTransfusion Transmitted Reaction.pptx
Transfusion Transmitted Reaction.pptx
 
female reproductive system.pptx
female reproductive system.pptxfemale reproductive system.pptx
female reproductive system.pptx
 
male Reproductive system.pptx
male Reproductive system.pptxmale Reproductive system.pptx
male Reproductive system.pptx
 
Cartilage&_Bone.pptx
Cartilage&_Bone.pptxCartilage&_Bone.pptx
Cartilage&_Bone.pptx
 
histology of epithelial and connective tissue.pptx
histology of epithelial and connective tissue.pptxhistology of epithelial and connective tissue.pptx
histology of epithelial and connective tissue.pptx
 
Digestive System Liver, Gall Bladder and Pancreas.pptx
Digestive System Liver, Gall Bladder and Pancreas.pptxDigestive System Liver, Gall Bladder and Pancreas.pptx
Digestive System Liver, Gall Bladder and Pancreas.pptx
 
LE cell.ppt
LE cell.pptLE cell.ppt
LE cell.ppt
 
Cytology stain.pptx
Cytology stain.pptxCytology stain.pptx
Cytology stain.pptx
 
Urinary System Histology.pptx
Urinary System Histology.pptxUrinary System Histology.pptx
Urinary System Histology.pptx
 
Alimentary system.pptx
Alimentary system.pptxAlimentary system.pptx
Alimentary system.pptx
 
MICROSCOPE (1).pptx
MICROSCOPE (1).pptxMICROSCOPE (1).pptx
MICROSCOPE (1).pptx
 
Nervous tissue.pptx
Nervous tissue.pptxNervous tissue.pptx
Nervous tissue.pptx
 
ENDOCRINE SYSTEM 2.pptx
ENDOCRINE SYSTEM 2.pptxENDOCRINE SYSTEM 2.pptx
ENDOCRINE SYSTEM 2.pptx
 
Investigation in mismatch blood transfusion.pptx
Investigation in mismatch blood transfusion.pptxInvestigation in mismatch blood transfusion.pptx
Investigation in mismatch blood transfusion.pptx
 
Normal hemostasis.pptx
Normal hemostasis.pptxNormal hemostasis.pptx
Normal hemostasis.pptx
 
Gland.pptx
Gland.pptxGland.pptx
Gland.pptx
 
differentialleucocytecount.pptx
differentialleucocytecount.pptxdifferentialleucocytecount.pptx
differentialleucocytecount.pptx
 
hemoglobinestimation2022-220717075634-6da2d22b (1).pptx
hemoglobinestimation2022-220717075634-6da2d22b (1).pptxhemoglobinestimation2022-220717075634-6da2d22b (1).pptx
hemoglobinestimation2022-220717075634-6da2d22b (1).pptx
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 

Recently uploaded (20)

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 

G6PD disease.pptx

  • 2.
  • 3. About G6PD Enzyme  It is the first enzyme of HMP Pathway which is the only source of NADPH in RBC.  Critical for protecting red cells against oxidant injury.  Active form of G6PD enzyme is a dimer.  Monomer – 515 amino acids  Molecular weight – 59 kd.
  • 5. Glucose-6-phosphate Dehydrogenase Deficiency is the most common enzyme deficiency affecting about 400 million people worldwide. Characterised by reduced activity of G6PD in RBCs and occurrence of hemolysis usually after exposure to oxidative stress.
  • 6.  G6PD located on X chromosome.  X linked recessive inheritence.
  • 7. Etiology G6PD deficiency , X-linked hereditary disorder caused by mutations in the G6PD gene at q28 locus. The q28 locus of the X- chromosome…
  • 8. Phenotype • As an X-linked disorder, G6PD deficiency mainly affect males. • Females are heterozygous, and mostly asymptomatic. • Expression of G6PD deficiency in females is variable, due to random inactivation of one X chromosome (lyonization) during embryogenesis and depends on relative proportion of normal and abnormal chromosome that are inactivated. • Homozygous females showing clinical features have also been reported.
  • 9. Classification of genetic Variants of G6PD  The World Health Organization classifies G6PD genetic variants into five classes on the basis of magnitude of enzyme deficiency and also on severity of hemolysis. The first three of which are deficiency states.  Class I- Very Severe deficiency (<10% activity) with chronic (nonspherocytic) hemolytic anemia  Class II -Severe deficiency (<10% activity), with intermittent hemolysis  Class III – Mild to Moderate deficiency (10-60% activity), hemolysis with stressors only  Class IV - Non-deficient variant, no clinical sequelae  Class V - Increased enzyme activity, no clinical sequelae
  • 10. Oxidative stress Bulidup of cellular oxidants Cross linking of – SH group of globin chain l/t denaturation Formation of membrane bound precipitates (Heinz bodies) Severely damage the membrane l/t IVH Less severe membrane damage l/t reduced deformability Heinz body containg RBCs passes through splenic cords ,macrophages pluck these bodies. Bite cells, Phagocytosed by splenic macrophages EVH
  • 11. G6PD Variants Variants Activity Hemolysis WHO class Race G6PD B Normal No Class IV Caucasians , Asians & Blacks G6PD A+ Normal No Class IV African Blacks G6PD A- Reduced Mild to Mod. Class III Blacks G6PD Mediterranean Markedly Reduced Severe Class II Caucasians G6PD Canton Markedly Reduced Severe Asians
  • 12. G6PD variants  There are over 400 variants of the G6PD enzyme.  G6PD A-: Most common type  Half life of enzyme – 13 days  Older RBCs are deficient in enzyme so on exposure to oxidative stress older RBCs are rapidly destroying. Whereas younger RBCs having enzymatic activity thus hemolytic episode is self limiting.  Confers protection against Malaria.  G6PD B: Enzyme normal  Half life of enzyme- 62 days  No hemolysis takes place.
  • 13. G6PD variants  G6PD Mediterranean :  Half life – 1 day  Severe hemolysis  Enzyme is deficient in both young & old red blood cells.  More severe than G6PD A.
  • 14. Common Variants in India  G6PD Mediterranean  G6PD Kerala-kalyan  G6PD orissa  G6PD deficiency commonly seen in Parsees and Vataliya Prajapatis
  • 15. • G6PD is the first enzyme in the hexose monophosphate shunt, a pathway critical for generating nicotinamide adenine dinucleotide phosphate (NADPH). • NADPH is required for the regeneration of reduced glutathione. • Reduced glutathione is used for the detoxification of oxidants produced by the interaction of hemoglobin and oxygen and by exogenous factors such as drugs, infection, and metabolic acidosis. Pathophysiology
  • 16. Pathogenesis  Normally when RBCs are exposed to drugs & toxins which generated free radicals , glucose metabolism via HMP shunt increased.  Larger amount of reduced glutathione is generated which inactivate oxygen radicals.
  • 18. Oxidative stress Bulidup of cellular oxidants Cross linking of – SH group of globin chain l/t denaturation Formation of membrane bound precipitates (Heinz bodies) Severely damage the membrane l/t IVH Less severe membrane damage l/t reduced deformability Heinz body containg RBCs passes through splenic cords ,macrophages pluck these bodies. Bite cells, Phagocytosed by splenic macrophages EVH
  • 19. Oxidative triggers  Infections:  Viral hepatitis  Typhoid fever  Pneumonia  Drugs  Antimalarial – Primaquine, Chloroquine  Sulfonamides – dapsone, Septran  Nitrofurantoin  Analgesics – Acetyl salicylic acid  Certain food  Fava beans
  • 20. Clinical Presentation  Acute hemolytic anemia  Drug induced  Infection induced  Neonatal hyperbilirubinemia  Hemolysis associated with diabetic acidosis  Favism  Chronic nonspherocytic hemolytic anemia
  • 21. Acute hemolytic anemia  Acute hemolysis usually occur after-  infection,  exposure to an oxidative drug.  Self limited- class III variant  affecting older erythrocytes first, younger erythrocytes and reticulocytes that typically have higher levels of enzyme activity are able to sustain the oxidative damage without hemolysis.  In class II variant, hemolysis is marked affecting all stages of RBC hence not self limited.  Hemolysis typically occurs- 24 to 72 hours after ingestion.  There is sudden development pallor,  dark coloured urine,  back or abdominal pain  Yellowish discolouration of skin and sclera.
  • 22. Favism  The disorder favism results from hemolysis secondary to the ingestion of fava bean.  Commonly associated with G6PD Mediterranean.  Most commonly seen in Italy, Greece and middle east.  Fava beans contain naturally occurring oxidants  Pyrimidine aglycone, devicine and isouramil.  Affects children 1-5 yrs of age.  Peak seasonal incidence April and May.  Characterized by acute intravascular hemolysis  Headache, nausea, back pain , fever with chills and rigors.  Followed by hemoglobinuria anemia and jaundice.
  • 23. Chronic nonspherocytic hemolytic anemia.  Patients with chronic nonspherocytic hemolytic anemia generally have a profound deficiency of G6PD that causes chronic anemia and an increased susceptibility to infection.  The susceptibility to infection arises because the NADPH supply within granulocytes is inadequate to sustain the oxidative burst necessary for killing of phagocytosed bacteria.
  • 24. Investigations  Complete blood count and reticulocyte count;  Peripheral smear for Heinz bodies  Liver enzymes (to exclude other causes of jaundice);  LDH (Lactate dehydrogenase) (elevated in hemolysis and a marker of hemolytic severity)  Haptoglobin (decreased in hemolysis);  A "direct antiglobulin test" (Coombs' test) – this should be negative, as hemolysis in G6PD is not immune-mediated;
  • 25. Lab findings  Fall in Hb to 6-10g/dl  Increased Reticulocyte count by 20-30 %  Inreased unconjugated bilirubin  Increased Urobilinogen  Increased LDH  Decreased Haptoglobin  Hemoglobinemia  Hemoglobinuria  Peripheral Smear shows-  Heinz Bodies  Fragmented red cells  Anisopoikilocytosis with polychromatic RBCs  Bite cells
  • 26. HEINZ BODIES : BITE CELLS
  • 27. Screening Test  Beutler fluorescent spot test  Methhemoglobin reduction test  Dye decolorisation test
  • 28. Fluoroscent Spot Test  Detecting the generation of NADPH from NADP. As NADPH fluoresce under UV light while NADP fails to do so. The test is positive if the blood spot fails to fluoresce under ultraviolet light.  Procedure  Reagent mixture + Whole Blood A Drop of This Mixture Applied to filter paper Examined under UV light Glucose 6 phosphate NADP Saponin & Oxidised glutathione
  • 29. Methhemoglobin Reduction Test  Sodium nitrite oxidises oxyhemoglobin to methhemoglobin  Methylene blue is a redox dye that reduces methhemoglobin to hemoglobin in G6PD normal red cell but not in deficient RBC.  Methhemoglobin imparts brownish color which indicate G6PD deficiency.
  • 31. Dye Decolourization Test  Hemolysate incubated with buffered solution of dichlorophenol Indophenol, glucose 6 phosphate, and NADP.  If G6PD exist in Hemolysate NADPH is generated which reduces the dye to colorless compound.  In G6PD deficiency time taken for dye decolourization is longer.
  • 32. Diagnosis  Quantitative G6PD assay  In patients with acute hemolysis, testing for G6PD deficiency may be falsely negative because older erythrocytes with a higher enzyme deficiency have been hemolyzed. Young erythrocytes and reticulocytes have normal or near-normal enzyme activity.  So enzyme assay should be performed 2-3 months after acute hemolysis.  Quantitative spectrophotometric analysis  Tests based on Polymerase chain reaction  detect specific mutations and are used for population screening, family studies, or prenatal diagnosis.
  • 33. G6PD deficiency should be suspected in patients of African, Mediterranean, or Asian ancestry who present with either an acute hemolytic episode or neonatal jaundice. The key to management of G6PD deficiency is prevention of hemolysis by prompt: 1- treatment of infections 2- avoidance of oxidant drugs (e.g., sulfonamides, sulfones, nitrofurans) and toxins (e.g., naphthalene). Although most patients with a hemolytic episode will not require medical intervention, those with severe anemia and hemolysis may require resuscitation and Treatment
  • 34. Correlation with Malaria • In areas in which malaria is endemic, G6PD deficiency has a prevalence of 5% to 25%; in nonendemic areas, it has a prevalence of less than 0.5% . • G6PD deficient RBC does not allow parasite to grow since the ribose metabolite required for nucleic acid synthesis in malaria parasite are not available. • This protection is largely limited to heterozygous females.

Editor's Notes

  1. As an X-linked disorder, G6PD deficiency predominantly and most severely affects males. Rare symptomatic females have a skewing of X chromosome inactivation such that the X chromosome carrying the G6PD disease allele is the active X chromosome in erythrocyte precursors.
  2. Sodium nitrte
  3. MB activate HMP which produces NADPH. This NADPH converts methHb (brown colored) into oxyHb (red color). In G6PD def. person NADPH not generated so methHb not converted into oxyHb and the color of sample remained brown .